This led to the development of the Oslo scoring system which identified negative predictive factors for overall survival including tumor size greater than 5.5 cm, disease progression on chemotherapy, plasma CEA > 80 μg/L, and time interval between primary tumor resection and liver transplant of less than 2 years (16). Here, CEACAM5 is linked to neoplasm.